Vitex (Womens Health).

Vitex acts as a dopamine D2 agonist at the pituitary to lower prolactin, and pyridoxal-5-phosphate is the cofactor for the decarboxylase that makes dopamine. The vitamin and the botanical meet on the same transmitter.

Magnesium modulates calcium entry into smooth muscle and supports normal neuromuscular calm across the monthly cycle. It is the conventional mineral partner in vitex formulas and works separately from the pituitary route.

Gamma-linolenic acid feeds dihomo-gamma-linolenic acid and the series one prostaglandins involved in normal breast and cycle comfort. That eicosanoid route is independent of vitex's hormonal one.

Black cohosh works through serotonergic and opioid receptor signalling rather than oestrogen receptors, covering midlife comfort. Vitex covers the prolactin and dopamine arm, so the two are combined without overlap.

Red clover isoflavones act as weak ligands at oestrogen receptor beta, a receptor-level effect at the tissue. Vitex works upstream at the pituitary, so the levels differ.

Mucuna supplies L-dopa and vitex agonises dopamine D2 receptors, so both push prolactin in the same downward direction. The combined dopaminergic load should be counted as one total rather than two.

Serotonergic tone raises prolactin release, the opposite of what vitex's dopaminergic action does. Combining them works one hormone in two directions at once.

Vitamin B6 is already stored against this slug for its role in amine metabolism, and riboflavin is the flavin cofactor sitting beside it in the same one-carbon cycle. FAD-dependent MTHFR generates the methyl folate that supports methylation of catechol intermediates. Where B6 is supplied for cyclical support, riboflavin covers the adjacent step. The link is settled biochemistry rather than a combination finding.

Evening primrose oil is already stored against this slug and supplies gamma-linolenic acid, which sits downstream of the zinc-dependent delta-6 desaturase step. Zinc is also structural in the DNA-binding domains of nuclear hormone receptors. That places it on both the fatty acid and the hormone signalling sides of this formulation category. Sustained zinc intake lowers copper absorption, which is the standing caution.

Calcium has been studied in randomised work for cyclical symptom scores, with the proposed route being mineral status rather than pituitary signalling. Chaste tree acts at dopamine D2 receptors on lactotroph cells. The two act at different levels, which is why they appear in the same products. No combination trial is cited here, so the pairing is additive by construction.

Chamomile has accompanied chaste tree in European herbal practice for cyclical comfort for a long time. Its apigenin content interacts with benzodiazepine binding sites in laboratory receptor work, which is mechanism rather than clinical demonstration. The combination is conventional rather than tested as a unit. Where other calming products are already in use, the direction is additive.

Lemon balm and chaste tree are combined in classic European cyclical formulations. The proposed mechanism for lemon balm, GABA transaminase inhibition, comes from in vitro enzymology rather than human trials. The two do not share a route, so the pairing is complementary. Additive calm is what to plan around when other sedating products are involved.

Chaste tree diterpenes bind pituitary dopamine D2 receptors and restrain prolactin release. Ashwagandha withanolides have been studied for effects on cortisol, a different output of the same hypothalamic-pituitary system. The pairing therefore touches neighbouring controls rather than the same one. No combination trial is cited here, so this stays mechanistic.

Where two products both touch dopaminergic tone, the net effect depends on the site of action and is not simply the sum. Chaste tree acts at pituitary D2 receptors; rhodiola constituents affect monoamine turnover more broadly in animal work. The overlap is worth naming rather than assuming addition. Read it as mechanistic overlap, not a demonstrated combined benefit.

Dang gui occupies a comparable place in Chinese herbal practice to chaste tree in European practice, and combination products commonly carry both. The grounding is formulation convention and tradition, not a trial. Its coumarin content is the reason to raise it with a clinician alongside blood-thinning medication. The pairing is stated at that confidence deliberately.

Prostaglandins drive uterine smooth muscle contraction, and ginger constituents reduce prostaglandin and leukotriene formation in laboratory systems. Chaste tree works higher up, on prolactin release. Combining them addresses two different levels. Ginger carries a mild antiplatelet direction that matters alongside blood-thinning medication.

Passionflower is a conventional partner in cyclical comfort blends and its flavonoid fraction shows GABA-A receptor activity in vitro. That is receptor-level evidence rather than a clinical outcome for the pair. Sedation compounds when other calming agents or medications are in play. Evening timing is the usual formulation answer.

Evening primrose oil, already stored here, is rich in gamma-linolenic acid, one of the more oxidisable dietary fatty acids. Alpha-tocopherol terminates peroxidation chains inside the oil phase, which is why oil-based capsules are routinely formulated with it. This is stabilisation chemistry as much as nutrition. Ascorbate regenerates the tocopheroxyl radical at the interface.

Steroid hormones and many botanical constituents leave the body as glucuronide conjugates, which bacterial beta-glucuronidase can cleave for reabsorption. Glucaro-1,4-lactone inhibits that enzyme and shifts the balance toward excretion. That is enzyme chemistry with a stated direction, not a demonstrated clinical effect. It also means exposure to anything else cleared by glucuronidation can change.

DIM forms from indole-3-carbinol under stomach acid and changes the ratio of 2-hydroxy to 16-alpha-hydroxy oestrogen metabolites through CYP1A1 induction. Chaste tree acts on prolactin release rather than on oestrogen metabolism, so the two touch different steps of one axis. Enzyme induction also means DIM can alter clearance of other compounds. That is the practical point of the row.

Silymarin has shown inhibition of CYP2C9, CYP3A4 and UGT-mediated conjugation in vitro, with human significance at ordinary intakes reported as modest and variable. Chaste tree constituents are conjugated for excretion, so a shared route is plausible. The two appear together in hormone-and-liver formulations. Regard it as a metabolic interaction to watch rather than a benefit.

Chaste tree acts through dopamine receptors, and dopaminergic input is one of the signals shaping the timing of pineal melatonin output. Melatonin in turn modulates hypothalamic gonadotropin-releasing hormone pulsatility. That makes the pairing a loop rather than two independent actions. The grounding is neuroendocrine mechanism from animal and laboratory work.

Iron requirement in menstruating adults is roughly double that of non-menstruating adults, which is why the reference intakes differ by sex and age band. That places iron beside any cycle-support formulation on requirement grounds rather than mechanism. Iron absorption is inhibited by tannins, calcium and phytate taken in the same dose, and ascorbate improves it. None of that involves chaste tree directly.

Ascorbate keeps dietary non-heme iron in the ferrous state that the DMT1 transporter carries, and it also competes with phytate and polyphenols for binding it. In a product category where iron requirement is elevated, that absorption chemistry matters. Ascorbate also regenerates alpha-tocopherol at the membrane interface, tying it to the vitamin E row. Both roles are textbook.

Ginkgo appears in some cyclical formulations alongside chaste tree. Its antiplatelet direction, mediated by ginkgolide B at the platelet-activating factor receptor, is the property worth stating rather than any combined benefit. That direction compounds with other antiplatelet agents. Anyone on anticoagulant or antiplatelet medication should raise it with a clinician.

Theanine, the characteristic amino acid of tea leaf, shifts alpha-band activity within about an hour of intake in human EEG studies. It is combined with cycle-support botanicals for calm without heavy sedation. Chaste tree does not act by that route, so the pairing is complementary rather than overlapping. Additive calm is the direction to plan around.